These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28338008)

  • 1. Noninvasive measurement of transdermal drug delivery by impedance spectroscopy.
    Arpaia P; Cesaro U; Moccaldi N
    Sci Rep; 2017 Mar; 7():44647. PubMed ID: 28338008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Richard Guy and his collaborators: 'crackling' the skin code.
    Delgado-Charro MB
    Skin Pharmacol Physiol; 2013; 26(4-6):302-12. PubMed ID: 23921117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of in vivo impedance spectroscopy techniques for measurement of micropore formation following microneedle insertion.
    Brogden NK; Ghosh P; Hardi L; Crofford LJ; Stinchcomb AL
    J Pharm Sci; 2013 Jun; 102(6):1948-1956. PubMed ID: 23589356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery.
    Wong TW
    J Control Release; 2014 Nov; 193():257-69. PubMed ID: 24801250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal iontophoresis: impact on skin integrity as evaluated by various methods.
    Kumar MG; Lin S
    Crit Rev Ther Drug Carrier Syst; 2008; 25(4):381-401. PubMed ID: 18540843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
    Patel N; Jain S; Lin S
    Int J Pharm; 2016 Nov; 513(1-2):393-403. PubMed ID: 27633278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.
    Yamamoto R; Takasuga S; Yoshida Y; Mafune S; Kominami K; Sutoh C; Kato Y; Yamauchi M; Ito M; Kanamura K; Kinoshita M
    Int J Pharm; 2012 Jan; 422(1-2):132-8. PubMed ID: 22108639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
    Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery.
    Blagus T; Markelc B; Cemazar M; Kosjek T; Preat V; Miklavcic D; Sersa G
    J Control Release; 2013 Dec; 172(3):862-71. PubMed ID: 24113487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide dendrimer-conjugates of ketoprofen: Synthesis and ex vivo and in vivo evaluations of passive diffusion, sonophoresis and iontophoresis for skin delivery.
    Hegde AR; Rewatkar PV; Manikkath J; Tupally K; Parekh HS; Mutalik S
    Eur J Pharm Sci; 2017 May; 102():237-249. PubMed ID: 28285173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R; Bokalial R; Sharma P; Khandavilli S
    Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermal and transdermal delivery of pharmaceutically relevant macromolecules.
    Münch S; Wohlrab J; Neubert RHH
    Eur J Pharm Biopharm; 2017 Oct; 119():235-242. PubMed ID: 28647443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic.
    Takasuga S; Yamamoto R; Mafune S; Sutoh C; Kominami K; Yoshida Y; Ito M; Kinoshita M
    J Pharm Pharmacol; 2011 Nov; 63(11):1437-45. PubMed ID: 21988424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation.
    Simon A; Amaro MI; Healy AM; Cabral LM; de Sousa VP
    Int J Pharm; 2016 Oct; 512(1):234-241. PubMed ID: 27568498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Skin Penetration Enhancers for Transdermal Gene and Drug Delivery.
    Amjadi M; Mostaghaci B; Sitti M
    Curr Gene Ther; 2017; 17(2):139-146. PubMed ID: 28494734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal drug delivery systems: skin perturbation devices.
    Brown MB; Traynor MJ; Martin GP; Akomeah FK
    Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the permselective properties of rabbit skin during transdermal iontophoresis.
    Nicoli S; Cappellazzi M; Colombo P; Santi P
    J Pharm Sci; 2003 Jul; 92(7):1482-8. PubMed ID: 12820152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.